Clinically Effective A. Marginale Bovine Vaccine Makes International Research News, Causes Global Excitement for Cattle Ranchers Currently Battling Anaplasmosis Epidemic
- Wednesday, June 1, 2022, 7:22
- PR Newswire
- Add a comment
‘For over 20 years now, our vaccine based on A. marginale rather than A. centrale has remained the best, most cost-effective protection in this ongoing battle against bovine anaplasmosis’ –Dr. Gene Luther, University Products LLC BATON ROUGE, La., June 1, 2022 /PRNewswire/ — University…